1 +/- 9 0 mL in “”VPD + MI”" group vs 102 9 +/- 10 3 mL in “”MI”

1 +/- 9.0 mL in “”VPD + MI”" group vs. 102.9 +/- 10.3 mL in “”MI”" group, P < .02), improved ejection

fraction (46.9 +/- 5.2% in “”VPD + MI”" group vs. 34.7 +/- 6.8% in “”MI”" group, P < .04) and preserved cardiac output (5.2 +/- 0.7 L/min in “”VPD + MI”" group vs. 5.0 +/- 1.8 L/min in “”MI”" group, P = NS), suggesting more efficient mechanical performance of the LV with the implanted VPD.

Conclusions: A significant reduction in LV volumes and corresponding improvement in LV function occurred after device implantation indicating a potential beneficial effect of this new device in treatment of post MI LV dilation. (I Cardiac Fad 2009:15:790-797)”
“The success of liver transplantation (LT) is accompanied by an increased need for organs. The wider use of older donors AZD7762 manufacturer and marginal organs with risk factors such as steatosis has lead to a new interest to improve the outcome with marginal organs. We herewith report a novel technique for LT with in situ preparation and immediate warm-ischemia liver transplantation (WI-LT). The aim of our

study was to demonstrate the technical feasibility and report the transplant course.

Six patients underwent WI-LT at our institution. Hepatectomies during procurement STI571 in vitro and LT were both performed in parallel by different surgical teams. Technical factors and postoperative allograft function were analyzed.

All six WI-LTs were performed without intraoperative complications with a mean warm-ischemia time (WIT) of 29.0 min. No patient

developed primary non-function or required retransplantation. Mean alanine aminotransferase (194.0 +/- 170.4 U/l) and aspartate aminotransferase MEK162 price (316.3 +/- 222.1 U/l) values on the first postoperative day were low, indicating a low ischemia/reperfusion injury and an excellent liver function.

These results demonstrate that WI-LT is a safe and technically feasible approach for LT with possibly reduced IRI and an excellent postoperative allograft quality. WI-LT may therefore be considered in individual patients especially with extended criteria donors to eventually improve postoperative allograft quality.”
“Background: Pleural empyema can be subdivided into 3 stages: exudative, multiloculated, and organizing. In the absence of clear septation, antibiotics plus simple drainage of pleural fluid is often sufficient treatment, whereas clear septation often requires more invasive treatment. Objectives: The aim of this study was to report our experience and analyze the safety and efficacy of medical thoracoscopy in patients with multiloculated and organizing empyema. Methods: We performed a retrospective study reviewing the files of patients referred for empyema and treated by medical thoracoscopy at our department from July 2005 to February 2011. Results: A total of 41 patients with empyema were treated by medical thoracoscopy; empyema was free flowing in 9 patients (22%), multiloculated in 24 patients (58.

Comments are closed.